SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: v177693_ex99-1.htm 2 EX-99.1
[v177693_ex99-1.htm 2 EX-99.1]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 Press Release Dated March 9, 2010 2]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 Press Release Dated March 9, 2010 2]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[] [EX-99.2 3 ex99-2.htm]
BSPM [Biostar Pharmaceuticals,] 8-K:
[] [EX-99.2 3 ex99-2.htm]
BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)
[ex99-1.htm 2 EX-99.1] [ex99-2.htm 3 EX-99.2]
BSPM [Biostar Pharmaceuticals,] 8-K: ex99-1.htm 2 EX-99.1
[ex99-1.htm 2 EX-99.1] [ex99-2.htm 3 EX-99.2]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G/A: (Original Filing)
[SCHEDULE 13G 3 (Amendment No. Skystar Bio-Pharmaceutical Company (Name of Issuer) Common Stock 830884102 May 05, 2009 o x o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] SC 13G/A: SCHEDULE 13G 3 (Amendment No. Skystar Bio-Pharmaceutical Company
[SCHEDULE 13G 3 (Amendment No. Skystar Bio-Pharmaceutical Company (Name of Issuer) Common Stock 830884102 May 05, 2009 o x o * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[EX-99.1 2 v176570_ex99-1.htm]
